<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://science-nature.marc8.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>vaccination</title>
 <link>http://science-nature.marc8.com/news-tags/vaccination</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>UCSB researchers develop cross-protective vaccine</title>
 <link>http://science-nature.marc8.com/ucsb-researchers-develop-cross-protective-vaccine</link>
 <description>&lt;p&gt;(University of California - Santa Barbara) Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect against, say, 2,500 strains of Salmonella. And what if that same vaccine could help protect the elderly?&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/ucsb-researchers-develop-cross-protective-vaccine#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/broad-spectrum">broad spectrum</category>
 <category domain="http://science-nature.marc8.com/news-tags/california-santa-barbara">california santa barbara</category>
 <category domain="http://science-nature.marc8.com/news-tags/salmonella">salmonella</category>
 <category domain="http://science-nature.marc8.com/news-tags/university-california-santa-barbara">university of california santa barbara</category>
 <category domain="http://science-nature.marc8.com/news-tags/vaccination">vaccination</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/9993</wfw:commentRss>
 <pubDate>Tue, 21 Oct 2008 00:00:00 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">9993 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Pneumococcal Vaccine Associated With 50 Percent Lower Risk Of He...</title>
 <link>http://science-nature.marc8.com/pneumococcal-vaccine-associated-50-percent-lower-risk-he</link>
 <description>&lt;p&gt;Pneumococcal (pneumonia) vaccination was associated with a 50 percent lower risk of heart attacks two years after vaccination, suggests a large hospital-based case-control study.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/414937064&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/pneumococcal-vaccine-associated-50-percent-lower-risk-he#comments</comments>
 <category domain="http://science-nature.marc8.com/news-tags/case-control-study">case control study</category>
 <category domain="http://science-nature.marc8.com/news-tags/heart-attacks">heart attacks</category>
 <category domain="http://science-nature.marc8.com/news-tags/pneumonia">pneumonia</category>
 <category domain="http://science-nature.marc8.com/taxonomy/term/18">risk</category>
 <category domain="http://science-nature.marc8.com/news-tags/vaccination">vaccination</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/9354</wfw:commentRss>
 <pubDate>Wed, 08 Oct 2008 13:01:49 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">9354 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>Novel Ways To Boost Vaccination Or Natural Defenses</title>
 <link>http://science-nature.marc8.com/novel-ways-boost-vaccination-or-natural-defenses</link>
 <description>&lt;p&gt;Our bodies rely on the production of potent, or &#039;high affinity,&#039; antibodies to fight infection. The process is very complex, yet scientists have discovered that it hinges on a single molecule, a growth factor, without which it cannot function.&lt;img src=&quot;http://feeds.sciencedaily.com/~r/sciencedaily/~4/328908001&quot; height=&quot;1&quot; width=&quot;1&quot; /&gt;&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/novel-ways-boost-vaccination-or-natural-defenses#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/affinity-antibodies">affinity antibodies</category>
 <category domain="http://science-nature.marc8.com/news-tags/molecule">molecule</category>
 <category domain="http://science-nature.marc8.com/news-tags/natural-defenses">natural defenses</category>
 <category domain="http://science-nature.marc8.com/news-tags/scientists">scientists</category>
 <category domain="http://science-nature.marc8.com/news-tags/vaccination">vaccination</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/5858</wfw:commentRss>
 <pubDate>Tue, 08 Jul 2008 23:00:08 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">5858 at http://science-nature.marc8.com</guid>
</item>
<item>
 <title>New technology for boosting vaccine efficiency</title>
 <link>http://science-nature.marc8.com/new-technology-boosting-vaccine-efficiency</link>
 <description>&lt;p&gt;(Cure Lab, Inc.) One of the most pressing biomedical issues is the development of techniques that increase the efficiency of vaccines. In a paper published on April 24, 2008 in the journal Vaccine, a Massachusetts biotechnology company, Cure Lab, Inc. has proposed a new technology for anti-viral and potentially anti-cancer vaccination. Cure Lab demonstrates that deriving a vaccine antigen in two forms and then applying these two forms in combination elicits a much stronger immune response.&lt;/p&gt;
</description>
 <comments>http://science-nature.marc8.com/new-technology-boosting-vaccine-efficiency#comments</comments>
 <category domain="http://science-nature.marc8.com/taxonomy/term/9">Top stories</category>
 <category domain="http://science-nature.marc8.com/news-tags/antigen">antigen</category>
 <category domain="http://science-nature.marc8.com/news-tags/biomedical-issues">biomedical issues</category>
 <category domain="http://science-nature.marc8.com/news-tags/biotechnology-company">biotechnology company</category>
 <category domain="http://science-nature.marc8.com/news-tags/immune-response">immune response</category>
 <category domain="http://science-nature.marc8.com/news-tags/vaccination">vaccination</category>
 <wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://science-nature.marc8.com/crss/node/4001</wfw:commentRss>
 <pubDate>Thu, 24 Apr 2008 00:00:00 -0500</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">4001 at http://science-nature.marc8.com</guid>
</item>
</channel>
</rss>
